Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

December 01, 2015 4:23 AM ET

Company Overview of Abramson Family Cancer Research Institute

Company Overview


United States

Key Executives for Abramson Family Cancer Research Institute

Compensation as of Fiscal Year 2015.

Abramson Family Cancer Research Institute Key Developments

Epic Sciences Collaborates with the Abramson Cancer Center of the University of Pennsylvania

Epic Sciences has collaborated with the Abramson Cancer Center of the University of Pennsylvania. It was reported that the collaboration is aimed at multiple studies to explore biomarkers, identified by analysis of circulating tumour cells at a single cell resolution, that are predictive of response to personalized cancer therapeutics.

Myriad Genetics, Inc. and Memorial Sloan Kettering Cancer Center, Mayo Clinic, Abramson Cancer Center of the University of Pennsylvania and Other Laboratories Team Up in Innovative Collaboration to Accelerate Hereditary Cancer Research

Myriad Genetics Inc. and Memorial Sloan Kettering Cancer Center (MSKCC), Mayo Clinic, Abramson Cancer Center of the University of Pennsylvania and other laboratories are teaming up in a new partnership that will dramatically advance the understanding of the risks associated with multiple cancer genes that are being analyzed through next generation sequencing technology. Specifically, the partners will collaborate on the creation of a research study called the Prospective Registry of Multiplex Testing (PROMPT). The goals of the study are three-fold: to create an online registry of individuals consenting to a prospective follow up after having been tested with a pan-cancer panel test such as Myriad's myRisk(TM) Hereditary Cancer; to provide infrastructure for the curation of specific genetic variants detected; and to facilitate additional studies to characterize the significance of the genetic mutations. Myriad will contribute thousands of genetic mutations and its scientific expertise gained from having tested over 1.3 million patients for hereditary cancer risk.

Similar Private Companies By Industry

Company Name Region
Sugar Foods Corporation United States
MKB Associates Inc United States
Truth Consulting NY, Inc. United States
Castlerock Security, Inc. United States
The Crown Grill at Circus Cafe United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Abramson Family Cancer Research Institute, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at